# Surviving PEA in Roanoke (SPEAR) Study

> **NCT05283850** · PHASE2,PHASE3 · RECRUITING · sponsor: **Carol Bernier** · enrollment: 342 (estimated)

## Conditions studied

- Cardiac Arrest
- Pulseless Electrical Activity

## Interventions

- **DRUG:** High Calcium, Low Sodium (HCLS) Crystalloid Therapy
- **DRUG:** High Calcium, High Sodium (HCHS) Crystalloid Therapy

## Key facts

- **NCT ID:** NCT05283850
- **Lead sponsor:** Carol Bernier
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-16
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 342 (ESTIMATED)
- **Last updated:** 2022-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05283850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05283850, "Surviving PEA in Roanoke (SPEAR) Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05283850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*